Clene Deferred Long Term Liab vs Common Stock Analysis

CLNNW Stock

USD 0.04 0 6.76%

Clene financial indicator trend analysis is way more than just evaluating Clene Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clene Inc is a good investment. Please check the relationship between Clene Deferred Long Term Liab and its Common Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Deferred Long Term Liab vs Common Stock

Deferred Long Term Liab vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clene Inc Deferred Long Term Liab account and Common Stock. At this time, the significance of the direction appears to have pay attention.

The correlation between Clene's Deferred Long Term Liab and Common Stock is -0.76. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Common Stock in the same time period over historical financial statements of Clene Inc, assuming nothing else is changed. The correlation between historical values of Clene's Deferred Long Term Liab and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Clene Inc are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Deferred Long Term Liab i.e., Clene's Deferred Long Term Liab and Common Stock go up and down completely randomly.

Correlation Coefficient

-0.76

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Common Stock

Most indicators from Clene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clene Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Clene's Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 64.5 M in 2025, whereas Enterprise Value Over EBITDA is likely to drop (0.75) in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	3.3M	4.6M	5.2M	5.5M
Depreciation And Amortization	1.4M	1.7M	2.0M	1.5M

Interest Expense Depreciation And Amortization

Clene fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Other Current Assets	Total Liab	Total Current Assets	Other Assets	Cash And Short Term Investments	Capital Surpluse	Other Stockholder Equity	Common Stock	Short Long Term Debt Total	Other Current Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total
Total Assets		0.71	0.38	-0.85	0.69	0.7	0.91	-0.88	0.9	0.86	0.79	-0.82	0.71	0.52	0.62	-0.59	-0.27	0.62	0.82	0.62	0.88	0.65	0.7	0.86	-0.89	-0.76
Total Current Liabilities	0.71		0.22	-0.92	0.68	0.58	0.7	-0.84	0.7	0.82	0.93	-0.79	0.83	0.25	0.83	-0.77	0.22	0.62	0.49	0.83	0.85	0.59	0.43	0.87	-0.8	-0.96
Total Stockholder Equity	0.38	0.22		-0.15	0.22	-0.38	0.17	-0.3	0.17	0.27	0.42	0.14	0.29	0.02	0.26	-0.29	0.05	0.21	0.19	0.26	0.28	0.23	0.16	0.28	-0.27	-0.31
Retained Earnings	-0.85	-0.92	-0.15		-0.84	-0.75	-0.87	0.96	-0.87	-0.95	-0.93	0.93	-0.9	-0.35	-0.85	0.81	-0.04	-0.78	-0.7	-0.85	-0.97	-0.78	-0.55	-0.97	0.95	0.96
Other Current Assets	0.69	0.68	0.22	-0.84		0.52	0.69	-0.86	0.65	0.88	0.8	-0.75	0.89	0.15	0.89	-0.82	0.23	0.98	0.5	0.89	0.86	0.96	0.2	0.88	-0.87	-0.83
Total Liab	0.7	0.58	-0.38	-0.75	0.52		0.77	-0.67	0.77	0.64	0.51	-0.93	0.49	0.48	0.43	-0.39	-0.28	0.47	0.66	0.43	0.68	0.48	0.56	0.65	-0.69	-0.56
Total Current Assets	0.91	0.7	0.17	-0.87	0.69	0.77		-0.93	1.0	0.91	0.81	-0.87	0.69	0.64	0.58	-0.55	-0.42	0.61	0.95	0.58	0.93	0.64	0.84	0.9	-0.94	-0.75
Other Assets	-0.88	-0.84	-0.3	0.96	-0.86	-0.67	-0.93		-0.93	-0.97	-0.95	0.87	-0.85	-0.46	-0.79	0.76	0.11	-0.8	-0.81	-0.79	-1.0	-0.81	-0.64	-0.98	1.0	0.92
Cash And Short Term Investments	0.9	0.7	0.17	-0.87	0.65	0.77	1.0	-0.93		0.88	0.81	-0.86	0.66	0.65	0.55	-0.53	-0.44	0.58	0.96	0.55	0.92	0.61	0.86	0.88	-0.94	-0.75
Capital Surpluse	0.86	0.82	0.27	-0.95	0.88	0.64	0.91	-0.97	0.88		0.92	-0.85	0.92	0.38	0.86	-0.78	-0.03	0.81	0.74	0.86	0.97	0.81	0.58	0.99	-0.97	-0.91
Other Stockholder Equity	0.79	0.93	0.42	-0.93	0.8	0.51	0.81	-0.95	0.81	0.92		-0.76	0.89	0.3	0.85	-0.83	0.1	0.75	0.65	0.85	0.95	0.75	0.52	0.95	-0.92	-0.98
Common Stock	-0.82	-0.79	0.14	0.93	-0.75	-0.93	-0.87	0.87	-0.86	-0.85	-0.76		-0.75	-0.41	-0.69	0.67	0.1	-0.7	-0.72	-0.69	-0.88	-0.71	-0.56	-0.86	0.87	0.81
Short Long Term Debt Total	0.71	0.83	0.29	-0.9	0.89	0.49	0.69	-0.85	0.66	0.92	0.89	-0.75		0.0	0.97	-0.94	0.34	0.84	0.46	0.97	0.87	0.85	0.29	0.92	-0.84	-0.94
Other Current Liab	0.52	0.25	0.02	-0.35	0.15	0.48	0.64	-0.46	0.65	0.38	0.3	-0.41	0.0		-0.03	0.22	-0.78	0.05	0.74	-0.03	0.44	0.0	0.76	0.39	-0.48	-0.18
Property Plant And Equipment Net	0.62	0.83	0.26	-0.85	0.89	0.43	0.58	-0.79	0.55	0.86	0.85	-0.69	0.97	-0.03		-0.89	0.47	0.84	0.31	1.0	0.8	0.81	0.13	0.88	-0.76	-0.91
Current Deferred Revenue	-0.59	-0.77	-0.29	0.81	-0.82	-0.39	-0.55	0.76	-0.53	-0.78	-0.83	0.67	-0.94	0.22	-0.89		-0.47	-0.83	-0.34	-0.89	-0.78	-0.87	-0.14	-0.79	0.74	0.89
Net Debt	-0.27	0.22	0.05	-0.04	0.23	-0.28	-0.42	0.11	-0.44	-0.03	0.1	0.1	0.34	-0.78	0.47	-0.47		0.29	-0.66	0.47	-0.09	0.23	-0.74	0.0	0.16	-0.24
Accounts Payable	0.62	0.62	0.21	-0.78	0.98	0.47	0.61	-0.8	0.58	0.81	0.75	-0.7	0.84	0.05	0.84	-0.83	0.29		0.43	0.84	0.81	0.98	0.09	0.8	-0.81	-0.79
Cash	0.82	0.49	0.19	-0.7	0.5	0.66	0.95	-0.81	0.96	0.74	0.65	-0.72	0.46	0.74	0.31	-0.34	-0.66	0.43		0.31	0.8	0.48	0.92	0.73	-0.84	-0.55
Non Current Assets Total	0.62	0.83	0.26	-0.85	0.89	0.43	0.58	-0.79	0.55	0.86	0.85	-0.69	0.97	-0.03	1.0	-0.89	0.47	0.84	0.31		0.8	0.81	0.13	0.88	-0.77	-0.92
Non Currrent Assets Other	0.88	0.85	0.28	-0.97	0.86	0.68	0.93	-1.0	0.92	0.97	0.95	-0.88	0.87	0.44	0.8	-0.78	-0.09	0.81	0.8	0.8		0.82	0.63	0.98	-1.0	-0.93
Long Term Debt	0.65	0.59	0.23	-0.78	0.96	0.48	0.64	-0.81	0.61	0.81	0.75	-0.71	0.85	0.0	0.81	-0.87	0.23	0.98	0.48	0.81	0.82		0.16	0.8	-0.82	-0.77
Net Receivables	0.7	0.43	0.16	-0.55	0.2	0.56	0.84	-0.64	0.86	0.58	0.52	-0.56	0.29	0.76	0.13	-0.14	-0.74	0.09	0.92	0.13	0.63	0.16		0.57	-0.64	-0.41
Common Stock Total Equity	0.86	0.87	0.28	-0.97	0.88	0.65	0.9	-0.98	0.88	0.99	0.95	-0.86	0.92	0.39	0.88	-0.79	0.0	0.8	0.73	0.88	0.98	0.8	0.57		-0.97	-0.94
Common Stock Shares Outstanding	-0.89	-0.8	-0.27	0.95	-0.87	-0.69	-0.94	1.0	-0.94	-0.97	-0.92	0.87	-0.84	-0.48	-0.76	0.74	0.16	-0.81	-0.84	-0.77	-1.0	-0.82	-0.64	-0.97		0.89
Non Current Liabilities Total	-0.76	-0.96	-0.31	0.96	-0.83	-0.56	-0.75	0.92	-0.75	-0.91	-0.98	0.81	-0.94	-0.18	-0.91	0.89	-0.24	-0.79	-0.55	-0.92	-0.93	-0.77	-0.41	-0.94	0.89

Click cells to compare fundamentals

Clene Account Relationship Matchups

Clene fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	68.2M	63.1M	44.5M	52.3M	60.2M	45.6M
Total Current Liabilities	11.7M	6.0M	13.9M	25.3M	29.1M	30.6M
Total Stockholder Equity	341K	12.6M	3.2M	13.4M	15.4M	16.2M
Retained Earnings	(153.6M)	(163.3M)	(193.2M)	(242.7M)	(218.5M)	(207.5M)
Other Current Assets	1.4M	2.6M	5.6M	2.5M	2.8M	2.2M
Total Liab	67.9M	50.5M	41.3M	39.0M	44.8M	44.5M
Total Current Assets	63.0M	54.6M	29.2M	38.9M	44.7M	30.8M
Cash And Short Term Investments	59.3M	50.3M	23.3M	35M	40.3M	32.5M
Capital Surpluse	4.5M	153.6M	175.7M	196.2M	225.7M	117.7M
Other Stockholder Equity	153.6M	175.7M	196.2M	255.9M	294.3M	309.0M
Short Long Term Debt Total	4.3M	24.0M	31.8M	32.2M	37.0M	21.0M
Other Current Liab	9.5M	3.1M	3.3M	3.7M	3.3M	3.6M
Property Plant And Equipment Net	5.3M	8.4M	15.2M	13.4M	15.4M	10.5M
Net Debt	(55.0M)	(26.2M)	13.5M	3.3M	3.8M	4.0M
Accounts Payable	1.1M	1.9M	3.0M	1.5M	1.7M	1.9M
Cash	59.3M	50.3M	18.3M	28.8M	25.9M	26.5M
Non Current Assets Total	5.3M	8.5M	15.3M	13.5M	15.5M	10.5M
Long Term Debt	1.9M	14.5M	19.3M	7.2M	8.2M	9.6M
Net Receivables	2.2M	1.6M	189K	1.3M	1.2M	946.1K
Common Stock Shares Outstanding	3.5M	3.1M	3.3M	5.2M	4.7M	5.2M
Liabilities And Stockholders Equity	68.2M	63.1M	44.5M	52.3M	60.2M	53.5M
Non Current Liabilities Total	56.2M	44.4M	27.4M	13.6M	12.3M	11.6M
Capital Lease Obligations	2.4M	5.0M	6.2M	5.5M	6.3M	4.7M
Inventory	191K	41K	43K	37K	33.3K	54.4K
Net Invested Capital	2.3M	31.7M	28.9M	40.0M	46.1M	48.4M
Property Plant And Equipment Gross	4.2M	8.4M	15.2M	20.3M	23.4M	11.8M
Accumulated Other Comprehensive Income	325K	233K	203K	199K	228.9K	220.2K
Net Working Capital	51.3M	48.6M	15.3M	13.5M	12.2M	21.4M
Short Term Debt	768K	986K	7.5M	20.1M	23.1M	24.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Clene Stock Analysis

When running Clene's price analysis, check to measure Clene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clene is operating at the current time. Most of Clene's value examination focuses on studying past and present price action to predict the probability of Clene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clene's price. Additionally, you may evaluate how the addition of Clene to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Clene Deferred Long Term Liab vs Common Stock Analysis

Deferred Long Term Liab vs Common Stock

Deferred Long Term Liab vs Common Stock Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Common Stock

Clene fundamental ratios Correlations

Clene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clene fundamental ratios Accounts

Also Currently Popular

Additional Tools for Clene Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Current Assets
Common Stock Shares Outstanding	+ 1.0	Other Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Common Stock Total Equity	+ 0.99	Capital Surpluse
Accounts Payable	+ 0.98	Other Current Assets
Long Term Debt	+ 0.98	Accounts Payable

Common Stock Shares Outstanding	- 1.0	Non Currrent Assets Other
Non Currrent Assets Other	- 1.0	Other Assets
Non Current Liabilities Total	- 0.98	Other Stockholder Equity
Common Stock Total Equity	- 0.98	Other Assets
Common Stock Shares Outstanding	- 0.97	Common Stock Total Equity
Common Stock Shares Outstanding	- 0.97	Capital Surpluse